| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.05 | 0.7 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |